CDER-2024-123839-Microfluidic Equipment for Organ-on-a-Chip Studies
Closed Pre-Solicitation Posted
Not the latest version. See the latest pre-solicitation from .
- Solicitation number
- FDA-RFQ-CDER-2024-123839
- Agency
-
FDA Office of Acquisition and Grant Services
Food and Drug Administration, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- AJ11 General Science And Technology R&D Services; General Science And Technology; Basic Research
- Place of performance
- Silver Spring, Maryland 20993, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
Paragraph 1:
The U.S. Food and Drug Administration (FDA) Office of Acquisition and Grants Services (OAGS) has a requirement to procure Microfluidic Equipment for Organ-on-a-Chip Studies under Request for Quote FDA-RFQ-CDER-2024-123839. The FDA intends to award this purchase order on a sole source basis to Fluigent, Inc., the sole manufacturer and supplier of the required equipment. The equipment must be similar and fully compatible with previously purchased items, and Fluigent is the only manufacturer that meets the specifications outlined in the Statement of Work. The FDA is seeking capability statements from any parties that believe they can meet the requirement by the response date of 12:00 p.m. EST on 05/27/2023.
Paragraph 2:
This procurement is not set aside for any specific business type. Fluigent, Inc., located at 73 Princeton St., Suite 310, N. Chelmsford, MA 01863, is the current and sole-source contractor for this requirement. The NAICS code associated with this procurement is 334516-Analytical Laboratory Instrument Manufacturing. The FDA anticipates awarding a fixed-price purchase order to Fluigent, Inc. within approximately fifteen (15) days after the date of this notice, unless the Government determines that another organization has the capacity to meet this requirement.
Notice text
The U. S. Food & Drug Administration, (FDA) Office of Acquisition and Grants Services (OAGS) has a requirement to procure: CDER-2024-123839-Microfluidic Equipment for Organ-on-a-Chip Studies, on a sole source basis. The Food and Drug Administration (FDA) intends to award this Sole Source purchase order to Fluigent, Inc., located at: Fluigent, Inc., 73 Princeton St., Suite 310, N. Chelmsford, MA 01863, Phone (978) 269-0347, Email: fluigentinc@fl uigent.com.
Files
| File | Type | Posted |
|---|---|---|
| NOS Notice of Intent to Sole Source.pdf |
Notice history
Show all 12
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| FDA/CDRH Scientific Technical Capacity for Regulatory Review | FDA Office of Acquisition and Grant Services | No set-aside | |
| 1-Year OEM Service Contract - (2) Revvity Celigo S Imaging Instruments (VRC) | National Institute of Allergy and Infectious Diseases | No set-aside | |
| NOI - 4D-Nucleofector Core Unit and X Unit | Office of Logisitics and Acquisition Operations | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity